An exploratory, observational study to evaluate the efficacy and safety of daptomycin in treating neutropenic patients with fever due to known or suspected gram positive infections in adult hemato-oncology patients.
Latest Information Update: 12 Nov 2019
At a glance
- Drugs Daptomycin (Primary)
- Indications Febrile neutropenia; Gram-positive infections
- Focus Therapeutic Use
- Sponsors Novartis
- 15 Apr 2013 New trial record